Product details

This case describes the efforts of Novartis, a leader in the pharmaceutical industry, to become a ''corporate citizen''. Novartis CEO Dr Daniel Vasella was among the first signers and Dr Klaus Leisinger, head of Novartis Foundation for Sustainable Development, served as well as an ambassador to the Global Compact under UN Secretary General Kofi Annan. The case outlines the challenges facing the pharmaceutical industry, specifically Novartis, and describes the frameworks, structures, policies and programs put in place by the company to achieve this goal. It also points out the pressures of various stakeholders, the tensions and dilemmas faced, as well as certain issues regarding corporate governance. Thus, this case provides an example, and a basis for discussion about the challenges of integrating corporate citizenship into day-to-day business, long-term strategic vision and corporate culture. The case can be used to help introduce key concepts and theories regarding corporate responsibility. Frameworks are introduced to evaluate the extent to which companies such as Novartis can become corporate citizens.